Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for Sandra J. Johnson´┐Ż
95.16
-1.06 (-1.10%)
Aug 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 94.38 - 96.29
52 week 81.79 - 109.49
Open 95.93
Vol / Avg. 9.20M/8.33M
Mkt cap 263.54B
P/E 16.75
Div/yield 0.75/3.15
EPS 5.68
Shares 2.77B
Beta 0.60
Inst. own 67%
Oct 12, 2015
Q3 2015 Johnson & Johnson Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 10, 2015
Johnson & Johnson at Wells Fargo Healthcare Conference - 12:05PM EDT - Add to calendar
Jul 14, 2015
Q2 2015 Johnson & Johnson Earnings Release
Jul 14, 2015
Q2 2015 Johnson & Johnson Earnings Call - Webcast
Jun 11, 2015
Johnson & Johnson at Goldman Sachs Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 25.39% 21.96%
Operating margin 32.28% 27.66%
EBITD margin - 35.39%
Return on average assets 13.90% 12.38%
Return on average equity 26.06% 22.70%
Employees 126,500 -
CDP Score - 99 B

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Company's subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 57
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 56
Bio & Compensation  - Reuters
Paulus A Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 53
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 56
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 52
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Mary C. Beckerle Ph.D. Director
Age: 60
Bio & Compensation  - Reuters
D. Scott Davis Director
Age: 63
Bio & Compensation  - Reuters
Mary Sue Sue Coleman Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters